GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a prominent focus in therapeutic investigation, largely due to its impressive impact on treating diseases such as second type diabetes and obesity. Recent research have demonstrated that beyond glucose control, GLP-1 medications offer promise for circulatory well-being and e